Overview
Dr. Kelly Casperson emphasizes that a family history does not preclude individuals from using hormone therapy and shares findings from the WHI study regarding estrogen use and breast cancer risk.
Hormone Therapy Eligibility
- No family history should automatically disqualify a patient from considering hormone therapy.
- Hormone therapy decisions should be individualized and not based solely on familial breast cancer risk.
WHI Study Findings
- The estrogen-only arm (conjugated equine estrogens, CEE) of the Women's Health Initiative (WHI) showed 20% less breast cancer incidence compared to the placebo group.
- These findings suggest that estrogen-only hormone therapy may have a reduced breast cancer risk in certain populations.
Recommendations / Advice
- Clinical decisions about hormone therapy should be discussed between patient and provider, considering personal and family medical history along with current evidence.